HPV-Associated Oropharyngeal Cancer in the HIV/AIDS Patient.
HPV-Associated Oropharyngeal Cancer in the HIV/AIDS Patient.
Cancer Treat Res. 2019;177:131-181
Authors: Cameron JE, Hagensee M
Abstract
Since their discovery as the etiologic agents of cervical cancer in the mid-1970s, human papillomaviruses (HPVs) have been linked with a growing number of epithelial-derived tumors, including head and neck squamous cell carcinomas. HPV demonstrates a particular predilection for causing tumors of the oropharynx, with the majority of cases involving infection with high-oncogenic risk HPV-16. People living with HIV are at increased risk of infection with HPV- and HPV-related oral complications even with adequate control of their HIV infection with antiretroviral therapy. In this chapter, we discuss the molecular mechanisms that underlie HPV-mediated oncogenesis in the oropharynx. We also describe the progress that has been made in understanding the epidemiology of oral HPV infection and the determinants of oral HPV-related pathology. Finally, we examine what can be done to treat and prevent oral HPV infection, benign lesions, and cancer, particularly in the context of the HIV-positive patient.
PMID: 30523624 [PubMed - in process]
Source: Cell Research - Category: Cytology Authors: Cameron JE, Hagensee M Tags: Cancer Treat Res Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Cervical Cancer | Cytology | Epidemiology | Epithelial Cancer | Genital Warts | Head and Neck Cancer | HIV AIDS | Oral Cancer | Oropharyngeal Cancer | Pathology | Squamous Cell Carcinoma